General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

People

The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 13 members and Prof. Lehner acts as chairman effective Annual General Meeting 2013 until July 31.

Download the Novartis organizational structure (40 KB)

  • Ulrich Lehner, Ph.D.
    Chairman a.i.

    Read biography:

  • Enrico Vanni, Ph.D.
    Vice Chairman

    Read biography:

  • Dimitri Azar, M.D., MBA

    Read biography:

  • Verena A. Briner, M.D.

    Read biography:

  • William Brody, M.D., Ph.D.

    Read biography:

  • Srikant Datar, Ph.D.

    Read biography:

  • Ann Fudge

    Read biography:

  • Pierre Landolt, Ph.D.

    Read biography:

  • Andreas von Planta, Ph.D.

    Read biography:

  • Charles L. Sawyers, M.D.

    Read biography:

  • Dr. Ing. Wendelin Wiedeking

    Read biography:

  • William T. Winters

    Read biography:

  • Rolf M. Zinkernagel, M.D.

    Read biography:

Corporate Secretary

  • Charlotte Pamer-Wieser, Ph.D.

    Read biography: